Triamcinolone

Generic Name: Triamcinolone

Brand Names: Allernaze, Aristocort, Aristocort R, Juulissa Pharmapak, Kenalog, Kourzeq, Marcaine, Nasacort, Oracort, Oralone, Pediaderm Ta, Triaderm, Trianex, Triderm, Triesence, Triloan Suik, Tritocin, Viaderm Kc, Xipere, Zilretta

Drug Type: Small Molecule

Chemical Formula: C_₂₁H_₂₇FO_₆

CAS Number: 124-94-7

Unique Ingredient Identifier: 1ZK20VI6TY

Background: Triamcinolone is a corticosteroid used to treat various inflammatory conditions in the body from allergic rhinitis to acute exacerbations of multiple sclerosis. Triamcinolone can be used as a one time adjunct treatment of osteoarthritic knee pain, or first line as a topical treatment of corticosteroid responsive dermatoses. Triamcinolone is more commonly see...

Indication: 肾上腺皮质激素类药。主要用于过敏性与自身免疫性炎症性疾病。由于本品潴钠作用较弱，故一般不用作肾上腺皮质功能减退的替代治疗。

Associated Conditions: Acne, Acne Vulgaris, Acute Gouty Arthritis, Allergic Contact Dermatitis, Allergic Rhinitis (AR), Allergic Skin Reaction, Alopecia Areata (AA), Ankylosing Spondylitis (AS), Aphthous Stomatitis, Asthma, Atopic Dermatitis, Autoimmune Hemolytic Anemia, Berylliosis, Bullous dermatitis herpetiformis, Chronic Eczema, Chronic Inflammatory Skin Diseases, Congenital Adrenal Hyperplasia (CAH), Congenital Hypoplastic Anemia, Contact Dermatitis, Crohn's Disease (CD), Dental Cavity, Dermatitis, Dermatomyositis (DM), Diaper Rash, Discoid Lupus Erythematosus (DLE), Edema of the cerebrum, Epicondylitis, Erythroderma, Fungal Infections, Fungal infectious disorders of the Beard, Fungal skin infection, Gingivitis, Haemorrhoids, Hemangiomas, Hypercalcemia, Inflammation of Mouth, Intertrigo, Itching of the Anus, Itching of the External Genitalia, Itching of the Foot, Itching of the genitals, Itching of the hand, Juvenile Idiopathic Arthritis (JIA), Keloids Scars, Leukemias, Lichen Planus (LP), Lichen simplex chronicus, Lymphoma, Macular Edema, Mycosis Fungoides (MF), Mycotic Eczema, Necrobiosis lipoidica diabeticorum, Neurodermatitis, Nummular Dermatitis, Ocular Inflammation, Ophthalmia, Sympathetic, Oral Erosive Lichen Planus, Otitis Externa, Pemphigus, Pericarditis, Polymyositis, Postherpetic Neuralgia, Primary adrenocortical insufficiency, Proteinuria, Psoriasis Vulgaris (Plaque Psoriasis), Psoriatic Arthritis, Psoriatic plaque, Pure Red Cell Aplasia, Purulent Wounds, Pyoderma caused by susceptible bacteria, Regional Enteritis, Rheumatoid Arthritis, Ringworm Folliculitis, Seborrheic Dermatitis, Seborrheic Dermatitis, Eczematous, Secondary Impetiginization, Secondary adrenocortical insufficiency, Secondary thrombocytopenia, Serum Sickness, Skin chapped, Stomatitis, Denture, Synovitis, Systemic Lupus Erythematosus, Temporal Arteritis, Tinea Corporis, Transfusion Reactions, Trichinosis, Tuberculosis (TB), Ulcerative Colitis, Urticaria, Uveitis, Wound Infections, Acute Bursitis, Acute Multiple sclerosis, Acute Rheumatic heart disease, unspecified, Acute Tenosynovitis, Corticosteroid-responsive dermatoses, Cutaneous candidiasis, Cystic tumour of the ganglia, Exfoliative erythroderma, Granuloma annulare lesions, Idiopathic eosinophilic pneumonias, Non-suppurative Thyroiditis, Oral infections, Oral lesions, Severe Erythema multiforme, Subacute Dermatitis, Eczematous, Symptomatic Sarcoidosis, Ulceration of the mouth, Ulcerative stomatitis

Associated Therapies: -

Clinical Trials

Dexmedetomidine Versus Triamcinolone Treatment in Carpal Tunnel Syndrome

Not Applicable

Recruiting

Conditions: Carpal Tunnel Syndrome

Interventions: Drug: Dexmedetomidine
Drug: Triamcinolone

First Posted Date: 2022-11-22

Last Posted Date: 2023-10-31

Lead Sponsor: Assiut University

Target Recruit Count: 60

Registration Number: NCT05624866

Locations: 🇪🇬
Assiut Universit Hospital, Assiut, Egypt

Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation

Phase 2

Recruiting

Conditions: Skin Inflammation
Allergic Contact Dermatitis

Interventions: Drug: Squaric Acid Dibutyl Ester
Other: Known patch test allergens
Device: Microneedle
Drug: Dupilumab
Device: Suction blistering
Drug: Adalimumab
Procedure: Skin punch biopsy
Drug: Ustekinumab
Drug: Guselkumab
Drug: Canakinumab
Drug: Sarilumab
Drug: Triamcinolone Acetonide
Drug: Betamethasone Valerate
Drug: Fluticasone Propionate

First Posted Date: 2022-09-10

Last Posted Date: 2024-05-23

Lead Sponsor: John Harris

Target Recruit Count: 45

Registration Number: NCT05535738

Locations: 🇺🇸
University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States

Oxulumis® Suprachoroidal Microcatherization of Triesence® in Diabetic Macular Edema

Phase 2

Completed

Conditions: Diabetic Macular Edema

Interventions: Drug: Triamcinolone Acetonide
Device: Semi-automated Suprachoroidal Microcatheter

First Posted Date: 2022-08-23

Last Posted Date: 2024-11-20

Lead Sponsor: Oxular Limited

Target Recruit Count: 25

Registration Number: NCT05512962

Locations: 🇺🇸
Retina Consultants of Texas - The Woodlands, Houston, Texas, United States
🇺🇸
Retina Consultants of Texas - Bellaire, Houston, Texas, United States
🇺🇸
California Retina Consultants, Bakersfield, California, United States

and more 3 locations

Trial Comparing Three Single Dose Injections for Knee Osteoarthritis

Phase 4

Terminated

Conditions: Osteoarthritis, Knee

Interventions: Drug: Monovisc 88 MG Per 4 ML Prefilled Syringe
Drug: Synvisc-One 48 MG in 6 ML Prefilled Syringe
Drug: Zilretta

First Posted Date: 2022-08-09

Last Posted Date: 2023-04-10

Lead Sponsor: Ohio State University

Target Recruit Count: 6

Registration Number: NCT05492851

Locations: 🇺🇸
Ohio State Outpatient Lewis Center, Lewis Center, Ohio, United States
🇺🇸
Jameson Crane Sports Medicine Institute, Columbus, Ohio, United States

Suprachoroidal Triamcinolone Versus Posterior Subtenon Triamcinolone Alone or Formulated in the Management of Diabetic Macular Edema.

Not Applicable

Completed

Conditions: Diabetic Macular Edema of Left Eye

Interventions: Drug: Formulated Triamcinolone
Drug: Triamcinolone Acetonide

First Posted Date: 2022-07-19

Last Posted Date: 2022-07-19

Lead Sponsor: Al-Azhar University

Target Recruit Count: 75

Registration Number: NCT05464953

Locations: 🇪🇬
Ehab tharwat, Damieta, New Damietta, Egypt

Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis

Phase 4

Recruiting

Conditions: Atopic Dermatitis

Interventions: Biological: Dupilumab
Drug: Vanicream- Experienced Dupilumab
Drug: Vanicream- Active
Drug: Vanicream- Dupilumab-naïve
Drug: Triamcinolone Acetonide
Drug: Hydrocortisone

First Posted Date: 2022-06-29

Last Posted Date: 2024-10-26

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 600

Registration Number: NCT05436535

Locations: 🇺🇸
Children's Hospital Los Angeles: Division of Clinical Immunology & Allergy, Los Angeles, California, United States
🇺🇸
University of Pennsylvania, Perelman Center for Advanced Medicine: Department of Dermatology, Philadelphia, Pennsylvania, United States
🇺🇸
North Carolina Children's Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology, Chapel Hill, North Carolina, United States

and more 7 locations